Corporate ActionOct 15, 2026, 09:31 AM
Ascentage Pharma Trustee Buys 200K Shares for RSU Scheme
AI Summary
Ascentage Pharma Group International announced on October 15, 2026, that its trustee purchased 200,000 existing shares on the open market for the 2022 RSU Scheme. The total cost for these shares was HK$5,778,916, averaging HK$28.89 per share, which represents approximately 0.05% of the company's total issued shares. This transaction brings the total shares held by the trustee for the scheme to 2,915,000.
Key Highlights
- Ascentage Pharma Group International's trustee purchased 200,000 shares on October 15, 2026.
- The share purchase was for the purpose of the 2022 RSU Scheme to satisfy RSUs upon vesting.
- The total consideration paid for the shares was HK$5,778,916.
- The average consideration per share was approximately HK$28.89.
- The purchased shares represent approximately 0.05% of the total issued shares.
- Following the purchase, the trustee holds a total of 2,915,000 shares under the Scheme.
Price Impact
More from AAPG